Skip to main content
TruScreen Group Limited logo

TruScreen Group Limited — Investor Relations & Filings

Ticker · TRU ISIN · NZTRUE0001S7 NZX Manufacturing
Open in API
Filings indexed 366 across all filing types
Latest filing 2023-07-17 Director's Dealing
Country NZ New Zealand
Listing NZX TRU

About TruScreen Group Limited

https://www.truscreen.com

TruScreen Group Limited develops and manufactures a proprietary cervical cancer screening system that utilizes opto-electrical technology for the real-time detection of precancerous and cancerous tissue. The system employs a single-use sensor to measure tissue response to specific electrical and optical stimuli, processing the data through an integrated algorithm to provide an immediate objective result. By eliminating the requirement for laboratory processing, tissue sampling, and specialized pathology infrastructure, the technology facilitates point-of-care screening in diverse clinical environments. The device is designed to address the limitations of traditional cytology, offering a non-invasive, portable solution that enhances the efficiency of screening programs and improves patient access to diagnostic results.

Recent filings

Filing Released Lang Actions
Director and Officer Change of Interest Notice
Director's Dealing Classification · 100% confidence The document is a disclosure notice regarding the acquisition of relevant interests in shares by a director or senior manager, specifically Anthony Ho, Chairman of TruScreen Group Limited. It details the number of shares held before and after the transaction, the nature of the interest, transaction date, and consideration paid. The document references sections of the Financial Markets Conduct Act 2013, indicating regulatory compliance for insider trading disclosures. There is no financial performance data, earnings information, or report content. The document is a formal notification of a director's dealing in shares, consistent with insider trading disclosures. Therefore, the document fits the category of Director's Dealing (DIRS).
2023-07-17 English
Truscreen Annual Report 31 March 2023
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2023 TruScreen Group Limited' and contains detailed sections typical of an annual report, including a Chairman's Letter, Corporate Directory, Directors' Report, Financial Statements, Auditor's Report, Governance, and Shareholder Information. It includes comprehensive financial data, operational highlights, management details, and strategic outlook for the fiscal year 2023. The length of the document (15,000 characters) and the depth of content confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K).
2023-06-30 English
Preliminary Results for FY2023
Earnings Release Classification · 95% confidence The document is titled 'Results announcement' and provides summarized financial results for the 12 months ending 31 March 2023, including revenue, net profit/loss, and net tangible assets per equity security. It explicitly states that 'Unaudited financial statements accompany this announcement,' indicating that this document itself is a brief announcement of financial results rather than a full detailed report. The document length is only 2489 characters, which is quite short and consistent with a brief results announcement rather than a comprehensive annual or interim report. There is no detailed financial data or analysis within this text, only summary figures and a reference to attached statements. According to the classification rules, such brief initial announcements of financial results are classified as Earnings Release (ER).
2023-05-30 English
CSCCP Endorses TruScreen Technology
Regulatory Filings Classification · 95% confidence The document is an announcement dated 16 May 2023 from TruScreen Group Limited regarding the inclusion of their cervical cancer screening technology in a new national medical guideline by the Chinese Society for Colposcopy and Cervical Pathology (CSCCP). The content focuses on the endorsement of the technology, its expected impact on sales, and background information about the company and technology. There are no financial statements, regulatory filings, or detailed financial data presented. The document is a corporate announcement about a product and guideline update rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a general company announcement about a significant business development. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2023-05-15 English
TruScreen Recognised in Authoritative China Blue Paper
Regulatory Filings Classification · 95% confidence The document is an announcement dated 8 May 2023 from TruScreen Group Limited, detailing recognition in an authoritative China Blue Paper on cervical cancer screening technology. It highlights the company's product and its clinical benefits, referencing endorsements and expected sales impact. The text is promotional and informative about a third-party publication recognizing the company, rather than presenting financial data, regulatory filings, or management changes. There is no indication of financial results, voting results, legal proceedings, or capital changes. The document is a public announcement of a recognition event, not a report or detailed financial filing. Therefore, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2023-05-07 English
Director and Officer Change of Interest Notice
Director's Dealing Classification · 100% confidence The document is a disclosure notice under the Financial Markets Conduct Act 2013, specifically about the acquisition of relevant interests in shares by a director or senior manager (Anthony Ho). It details the number of shares held before and after the transaction, the nature of the transaction (on market purchase), and the consideration paid. The document includes certification by an authorized person but does not contain financial statements or company performance data. This type of filing corresponds to a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades).
2023-05-07 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.